Navigation Links
Psyche's Anatomic Pathology System Scores #1 for the KLAS Market Segment Anatomic Pathology for 2010

MILFORD, Mass., Jan. 25, 2011 /PRNewswire/ -- Psyche Systems' WindoPath® anatomic pathology information system ranked #1 among all anatomic pathology software solutions surveyed according to the 2010 Top 20 Best in KLAS Awards: Software & Professional Services report*. The report was published in December, 2010.

WindoPath is a highly advanced, full-featured anatomic pathology information system with a modular, customizable design. This design allows quick and easy adaptation to the specific needs of laboratories of all sizes and testing capabilities, including hospitals, private pathology groups, commercial labs, physician office labs, cytogenetics, reference and molecular labs. It is a complete Anatomic Pathology System with CLIA compliance and HIPAA-related security and privacy provisions.

Psyche Systems would like to thank all WindoPath customers who participated in the KLAS survey analysis. WindoPath's rating was 86.5, significantly higher than the closest competitor in Anatomic Pathology and was the only vendor in the category with a disclosure level of 'Full'.  Psyche was also the vendor rated to have 100% of customers surveyed say that they would buy Psyche again.

Dr. Michael Hitchcock, MBChB, MBA, of Pathologists Diagnostic Laboratory PA says, "The only thing wrong with Psyche's WindoPath is that all of our competitors are buying it."

For over 34 years, Psyche has delivered information systems designed exclusively for the pathology laboratory, pioneering many of the industry's leading technology innovations. Psyche developed the first client-server computing model for an AP system, integrated word processing for easier report creation and image management, interactive voice for Pap cases, choice of a stand-alone or a hosted software delivery model, and unified clinical/AP reporting capabilities.

About Psyche Systems Corporation

Founded in 1976, Psyche Systems Corporation has been a trusted partner to laboratories for over 30 years, delivering products and services to help laboratory environments run more efficiently and cost-effectively. For more information, visit

About KLAS

KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to, email, or call 1-800-920-4109 to speak with a KLAS representative.

* © 2010 KLAS Enterprises, LLC. All rights reserved.

SOURCE Psyche Systems Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
2. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
3. Omnyx Licenses Olympus Digital Pathology Patents
4. Olympus America Licenses Digital Pathology Patents to BioImagene, Inc.
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
7. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
8. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
9. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
10. New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):